Group 1 - The core viewpoint of the article is that Green New Biotechnology (01084) reported a decline in revenue and a shift to a loss for the first half of 2025 [1] - The company's revenue for the first half of 2025 was 410 million, representing a year-on-year decrease of 10.7% [1] - The company reported a loss attributable to shareholders of 12.068 million, marking a transition from profit to loss compared to the previous year [1] Group 2 - The loss per share for the company was 0.014 [1] - The decrease in revenue was primarily attributed to a decline in both the sales volume and sales prices of carrageenan and agar during the first half of 2025 [1]

Core Viewpoint - Green New Biotechnology (01084) reported a decline in revenue for the first half of 2025, primarily due to decreased sales volume and prices of carrageenan and agar products [1] Financial Performance - Revenue for the first half of 2025 was 410 million yuan, representing a year-on-year decrease of 10.7% [1] - The company reported a loss attributable to shareholders of 12.068 million yuan, marking a shift from profit to loss compared to the previous year [1] - Earnings per share were reported at a loss of 0.014 yuan [1] Product Performance - The decline in revenue was mainly attributed to the reduced sales volume and selling prices of carrageenan and agar products [1]